Regeneron Investigational Site is a clinical research site located in New London, Connecticut, United States.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Regeneron Investigational Site has participated in 1 clinical trials.
Therapeutic areas: Neovascular Age-Related Macular Degeneration.
Sponsors: Regeneron Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Regeneron Investigational Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Regeneron Investigational Site has 1 clinical trials on record. Their work covers Neovascular Age-Related Macular Degeneration.
Regeneron Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.